CAL-MAINE FOODS INC quarterly report, Q3 FY2024

Cal-Maine Foods, Inc. — Form 10-Q Summary

Reporting period: Fiscal 2024 third quarter, 13 weeks ended March 2, 2024; year-to-date covers 39 weeks. The filing was signed April 2, 2024. Comparisons below are with the corresponding prior-year periods.

Business context and results

Cal-Maine is a vertically integrated U.S. producer, processor, marketer and distributor of shell eggs, with one reportable segment. Results are highly sensitive to volatile egg selling prices and feed costs. The third-quarter comparison is against a prior-year period with unusually high egg prices amid HPAI-related supply constraints.

MetricThird quarter39 weeks year to date
Net sales$703.1 million, down 29.5%$1,685.7 million, down 31.4%
Gross profit / margin$218.6 million / 31.1%; prior year $463.0 million / 46.4%$355.1 million / 21.1%; prior year $998.4 million / 40.6%
Operating income$162.8 million, versus $407.8 million$170.3 million, versus $831.5 million
Net income attributable to Cal-Maine$146.7 million; diluted EPS $3.00, versus $323.2 million and $6.62$164.6 million; diluted EPS $3.37, versus $647.1 million and $13.25
Net cash from operationsNot presented for the quarter alone$237.6 million, versus $706.5 million

Quarterly shell-egg volume rose 3.2% to 300.8 million dozen, a company record, while average selling price fell to $2.247 per dozen from $3.298. Conventional egg price fell to $2.152 from $3.678 per dozen; specialty egg price fell to $2.415 from $2.616. Specialty eggs represented 38.5% of quarterly sales, compared with 28.2% a year earlier. Lower conventional egg prices were the principal cause of lower revenue and profit; lower feed costs partly offset the pressure. Farm production cost per dozen declined 10.5% in the quarter, mainly because feed cost per dozen fell 19.9%.

Cash, debt and liquidity

  • At March 2, cash and cash equivalents were $367.1 million and current available-for-sale investments were $327.7 million. Current assets were $1.218 billion and current liabilities $215.7 million; working capital was approximately $1.002 billion and the current ratio was 5.7.
  • Total liabilities were $412.6 million; the company reported no long-term debt and no borrowings under its $250 million revolving facility. It had $4.3 million of standby letters of credit.
  • Year-to-date operating cash flow was $237.6 million. Investing activities used $118.4 million, including the Fassio acquisition and $96.0 million of capital expenditures. Financing activities used $44.9 million, including $43.0 million of dividends. Cash increased $74.3 million from fiscal year-end.
  • Management said cash, investments, operating cash flow and the credit facility should fund current needs for at least 12 months.

Material changes, outlook and unusual items

  • Acquisition and investment: In September 2023, Cal-Maine acquired Fassio Egg Farms assets for estimated consideration of $54.7 million, including $1.0 million of contingent consideration. The business added capacity for approximately 1.2 million laying hens, primarily cage-free. On March 14, 2024, the company completed its acquisition of a closed Tyson broiler plant, hatchery and feed mill in Dexter, Missouri, which it plans to repurpose for egg and egg-products production.
  • HPAI: During the quarter, an outbreak at Kansas facilities led to depopulation of approximately 1.5 million laying hens and 240,000 pullets. After quarter-end, a Texas facility tested positive on April 1, affecting approximately 1.6 million laying hens and 337,000 pullets, or 3.6% of the March 2 flock. The company expects to repopulate the Texas facilities and resume normal operations within 6–8 months; it could not reasonably estimate the net income effect due to market uncertainty. USDA indemnity programs may compensate for certain direct losses.
  • Litigation accrual: A December 2023 jury awarded $17.8 million in damages in the Kraft processed egg-products antitrust case. Potential treble damages were stated as $53.3 million before credits and attorneys’ fees; the decision is not final and remains subject to post-trial proceedings and appeals. Cal-Maine accrued $19.6 million for its estimated proportional share, which could change. The company says it will continue to defend the case.
  • Other legal exposure: In the Oklahoma watershed case, the court found defendants liable but assessed no penalties; remedies remain unresolved and management says a potential monetary exposure cannot presently be estimated. Management considered material loss reasonably possible. Management considers material loss in the Texas state case remote; the Fifth Circuit affirmed dismissal of the related Bell consumer case in February 2024.
  • Other unusual item: The company recorded a $9.9 million gain on involuntary conversions in the quarter, primarily from insurance and indemnity recoveries. Year-to-date income tax expense included a $6.4 million discrete benefit; excluding it, the adjusted effective tax rate was 24.5%.
  • Dividends and capital projects: A $0.997-per-share dividend, totaling approximately $48.9 million, was declared for the quarter, payable May 16, 2024. Approved construction projects totaled $233.6 million, with $81.3 million remaining projected cost as of March 2, primarily for cage-free facilities, a feed mill and Dexter renovations.
  • Outlook and risks: The filing gives no specific revenue or earnings guidance. Management highlighted egg-price and feed-cost volatility, HPAI outbreaks, seasonality, cage-free supply and demand, inflation, labor and facility costs, and litigation. It noted that customer cage-free goals and state requirements are increasing, but future customer quantities are difficult to predict. Corn indications suggested potentially lower near-term prices, while weather and supply-chain uncertainty could sustain volatility.

Most important facts for investors to verify

  • Whether egg prices, flock supply and feed costs continue to normalize or experience renewed volatility, and how that affects margins.
  • The production, customer-supply and compensation effects of the Kansas and post-quarter Texas HPAI outbreaks, including the expected Texas recovery timeline.
  • Developments in the Kraft antitrust post-trial proceedings, appeals, settlement-credit discussions and the adequacy of the $19.6 million accrual; also monitor remedies in the Oklahoma case.
  • Integration and returns from the Fassio acquisition and Dexter repurposing, alongside the remaining $81.3 million of approved project costs.
  • Whether operating cash flow and liquidity remain adequate as earnings decline and planned capital spending proceeds.